Found: 14
Select item for more details and to access through your institution.
The impact of HER2-low status on response to neoadjuvant chemotherapy in clinically HER2-negative breast cancer.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 6, p. 1673, doi. 10.1007/s12094-022-03062-9
- By:
- Publication type:
- Article
Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.891175
- By:
- Publication type:
- Article
Hinokitiol-iron complex is a ferroptosis inducer to inhibit triple-negative breast tumor growth.
- Published in:
- Cell & Bioscience, 2023, v. 13, n. 1, p. 1, doi. 10.1186/s13578-023-01044-0
- By:
- Publication type:
- Article
PD-L1 lncRNA splice isoform promotes lung adenocarcinoma progression via enhancing c-Myc activity.
- Published in:
- Genome Biology, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s13059-021-02331-0
- By:
- Publication type:
- Article
PTP1B markedly promotes breast cancer progression and is regulated by miR‐193a‐3p.
- Published in:
- FEBS Journal, 2019, v. 286, n. 6, p. 1136, doi. 10.1111/febs.14724
- By:
- Publication type:
- Article
Integrated analysis of long noncoding RNA interactions reveals the potential role in progression of human papillary thyroid cancer.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 11, p. 5394, doi. 10.1002/cam4.1721
- By:
- Publication type:
- Article
Expression and significance of caveolin-1 in hepatitis B virus-associated hepatocellular carcinoma.
- Published in:
- Experimental & Therapeutic Medicine, 2017, v. 14, n. 5, p. 4356, doi. 10.3892/etm.2017.5038
- By:
- Publication type:
- Article
Stabilization of IGF2BP1 by USP10 promotes breast cancer metastasis via CPT1A in an m6A-dependent manner.
- Published in:
- International Journal of Biological Sciences, 2023, v. 19, n. 2, p. 449, doi. 10.7150/ijbs.76798
- By:
- Publication type:
- Article
Effectiveness and Safety of Zercepac and Reference Trastuzumab in the Neoadjuvant Setting for Early-Stage Breast Cancer: A Retrospective Cohort Study.
- Published in:
- Journal of Oncology, 2022, v. 2022, p. 1, doi. 10.1155/2022/9998114
- By:
- Publication type:
- Article
QL1209 (pertuzumab biosimilar) versus reference pertuzumab plus trastuzumab and docetaxel in neoadjuvant treatment for HER2-positive, ER/PR-negative, early or locally advanced breast cancer: A multicenter, randomized, double-blinded, parallel-controlled, phase III equivalence trial
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 4, p. 668, doi. 10.1038/s41416-024-02751-2
- By:
- Publication type:
- Article
Resumption of Intravenous Anti-Cancer Therapy in Breast Cancer: A Real-World Experience During the SARS-CoV-2 Pandemic.
- Published in:
- Cancer Management & Research, 2024, v. 16, p. 1, doi. 10.2147/CMAR.S444783
- By:
- Publication type:
- Article
Molecular characterization of papillary thyroid carcinoma: a potential three-lncRNA prognostic signature.
- Published in:
- Cancer Management & Research, 2018, v. 10, p. 4297, doi. 10.2147/CMAR.S174874
- By:
- Publication type:
- Article
Protein disulfide isomerase family member 4 promotes triple-negative breast cancer tumorigenesis and radiotherapy resistance through JNK pathway.
- Published in:
- Breast Cancer Research, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13058-023-01758-6
- By:
- Publication type:
- Article
Particular distribution and expression pattern of endoglin (CD105) in the liver of patients with hepatocellular carcinoma.
- Published in:
- BMC Cancer, 2007, v. 7, p. 122, doi. 10.1186/1471-2407-7-122
- By:
- Publication type:
- Article